New Research Poster 5 (open)
New Research Posters Session 5

Friday, October 30, 2015: 12:30 PM-3:00 PM
 
5.1
Emotional Face Processing Among Young Adults With Bipolar Disorder and Major Depressive Disorder
Jorge R. Almeida, MD, PhD Brown University, Providence, RI
Alexandra B. Weissman, BA Bradley Hospital PediMIND Program and Brown University, Riverside, RI
Grace K. Cushman, BS Bradley Hospital PediMIND Program and Brown University, East Providence, RI
Erin Bojanek Bradley Hospital, East Providence, RI
Kerri L. Kim, PhD Bradley Hospital PediMIND Program and Brown University, East Providence, RI
Laura Thomas, PhD National Institute of Mental Health, Bethesda, MD
Wan-Ling Tseng National Institute of Mental Health, Bethesda, MD
Ellen Leibenluft, MD National Institute of Mental Health, Bethesda, MD
Daniel P. Dickstein, MD Bradley Hospital PediMIND Program and Brown University, East Providence, RI
 
5.2
Theta Burst Stimulation Reveals Deficits in Cortical Plasticity and Correlates With Symptom Severity in Adolescent Females With Major Depression
Ernest Pedapati, MD, MS Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Steve Wu, MD, MS Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Paul Horn, PhD Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Donald L. Gilbert, MD, MS Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Cameron Laue, BS Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Elana Harris, MD, PhD Cincinnati Children's Hospital Medical Center, Cincinnati, OH
 
5.3
A Pilot Trial of the College Sleep Improvement Plan (CSIP)
Argelinda Baroni, MD New York University, New York, NY
Christina Di Bartolo NYU Langone Medical Center, New York, NY
Jean-Marie Bruzzese, PhD NYU Langone Medical Center, New York, NY
Jess P. Shatkin, MD, MPH New York University School of Medicine, New York, NY
 
5.4
The 7 Vital Connections: A Biopsychosocial-Spiritual Model
Joy Jones-Harris, MD, MA, MPH Loma Linda University Behavioral Medicine Center, Redlands, CA
Ricardo Whyte, MD Loma Linda University Behavioral Medicine Center, Redlands, CA
 
5.5
The Effects of BDNF on Treatment Response in Youth With Mood Disorders
Alexandra R. Bonner, BS The Ohio State University College of Medicine, Columbus, OH
Barbara Gracious, MD Nationwide Children's Hospital and The Ohio State University, Columbus, OH
Adina M. Seidenfeld, PhD The Ohio State University, Columbus, OH
Andrea S. Young, PhD Johns Hopkins University, Baltimore, MD
Mary A. Fristad, ABPP, PhD The Ohio State University, Columbus, OH
 
5.6
Recent Advances in Dup15q Syndrome: Can Genetics Facilitate the Identification of Clinically Meaningful Subgroups Within the Autism Spectrum?
Shafali S. Jeste, MD UCLA Center for Autism Research and Treatment, Los Angeles, CA
Charlotte Mucchetti, PhD University of California, Los Angeles, Los Angeles, CA
Edwin H. Cook Jr., MD University of Illinois at Chicago, Chicago, IL
 
5.7
Zebrafish Mutants of the Autism Risk Gene Cntnap2 Identify GABAergic Defects and Estrogens as Phenotypic Suppressors of a Behavioral Phenotype
Ellen J. Hoffman, MD, PhD Yale University, New Haven, CT
Kate Turner, BS University College London, London United Kingdom
Joseph Fernandez, BS Yale University, New Haven, CT
Steve Wilson, PhD University College London, London United Kingdom
Jason Rihel, PhD University College London, London United Kingdom
Matthew State, MD, PhD University of California, San Francisco, San Francisco, CA
Antonio J. Giraldez, PhD Yale University, New Haven, CT
 
5.8
Pharmacogenetic Study Focused on Fluoxetine Pharmacodynamics in Children and Adolescent Patients: Impact of the Serotonin Pathway
Astrid Morer, MD, PhD IDIBAPS , CIBERSAM, Barcelona Spain
Luisa Lazaro, PhD Hospital Clínic of Barcelona, IDIBAPS, CIBERSAM, University of Barcelona, Barcelona Spain
Sergi Mas, PhD University of Barcelona, Barcelona Spain
Ana Blazquez, PhD Fundació Clínic per a la Recerca Biomèdica, Barcelona Spain
Natalia Rodriguez, MS University of Barcelona, Barcelona Spain
Daniel Boloc, ScM University of Barcelona, Barcelona Spain
M. Teresa Plana, MD Hospital Clínic of Barcelona, Barcelona Spain
Am‡lia Lafuente, PharmD University of Barcelona, Barcelona Spain
Patricia Gasso, PharmD University of Barcelona, Barcelona Spain
 
5.9
Genetic Contributions to Cardiovascular Side Effects of Common ADHD Treatments
Erika Nurmi, MD, PhD University of California, Los Angeles, Los Angeles, CA
James J. McGough, MD UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA
Karyn S. Mallya, BA University of California, Los Angeles, Los Angeles, CA
Gerhard S. Hellemann, PhD University of California, Los Angeles, Los Angeles, CA
James T. McCracken, MD UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA
 
5.10
Diagnostic Validity of Schedule for Affective Disorders and Schizophrenia for School Aged Children (K-SADS)
Hakan Jarbin, MD Child and Adolescent Psychiatry Halland Sweden, Halmstad Sweden
Markus Andersson Child and Adolescent Psychiatry Halland Sweden, Träslövsvägen 25 a Sweden
Per K. Teigen, MD Regional Center for Child & Adolescent Mental Health, Oslo Norway
Maria Rastam, MD Lund University, Lund Sweden
Tord Ivarsson, MD, PhD The Center for Child and Adolescent Mental Health, Eastern and Southern Norway, Oslo Norway
 
5.11
An "Atypical" Presentation of Neuroleptic Malignant Syndrome in an Adolescent
Amandeep Jutla, MD UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA
Natalie Ramos, MD, MPH UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA
 
5.12
Utilization of Child Behavioral Checklist in Predicting Severity of Crime in Delinquent Youth
Sarper Taskiran, MD Koc University School of Medicine, Istanbul Turkey
Yavuz Ince Koc University School of Medicine, Istanbul Turkey
Evren Tufan, MD Abant Izzet Baysal University Medical Faculty, Bolu Turkey
Bengi Semerci, MD Bengi Semerci Institute, Istanbul Turkey
 
5.13
Development of a New Rating Scale for Psychiatric Symptoms in Children
David L Pogge, PhD Four Winds Hospital, Katonah, NY
Derek Nagy, PhD Centennial School District, Portland, OR
John Stokes, PhD Pace University, New York, NY
Philip D. Harvey, PhD Miller University of the Miami School of Medicine, Miami, FL
 
5.14
DSM-5: ADHD A-Criteria Changes Increase Symptom Endorsement Rates in Adolescents
Margaret H. Sibley, PhD Florida International University, Miami, FL
 
5.15
Comparing a Telehealth Diagnostic Approach for Autism Spectrum Disorder to the Standard In-Person Assessment
Christopher Smith, PhD Southwest Autism Research & Resource Center, Phoenix, AZ
Raun Melmed, MD Melmed Center, Scottsdale, AZ
 
5.16
Comparison of Two Measures of Working Memory Impairments in 220 Adolescents and Adults With ADHD
Thomas E. Brown, PhD Yale Medical School, Hamden, CT
Donald M. Quinlan, PhD Yale New Haven Hospital, New Haven, CT
Ryan J. Kennedy, RN Quinnipiac University, North Haven, CT
 
5.17
Disruptive Mood Dysregulation Disorder Symptoms in Children With Autism, ADHD, and Neurotypical Development and Impact of Co-Occurring Oppositional Defiant Disorder, Depression, and Anxiety
Susan D. Mayes, PhD Penn State Hershey College of Medicine, Hershey, PA
James Waxmonsky, MD Penn State College of Medicine, Hershey, PA
Susan L. Calhoun, PhD Penn State College of Medicine, Hershey, PA
Cari Kokotovich Penn State Hershey Medical Center, Hershey, PA
Christine Mathiowetz Penn State Hershey Medical Center, Hershey, PA
Raman Baweja, MD Penn State Milton S. Hershey Medical Center, Hershey, PA
 
5.18
Manville Moves: Engagement in and Uptake of an Exergaming Biking Curriculum for Children With Social and Emotional Disabilities at a Therapeutic Day School
April B. Bowling, MA Harvard T.H. Chan School of Public Health, Boston, MA
 
5.19
Mobile Bridge Therapy Program
Peng Pang, MD Stony Brook University Hospital, Stony Brook, NY
Gabrielle A. Carlson, MD Stony Brook University, Stony Brook, NY
 
5.20
Association of Trait Anxiety With State Anxiety and Its Prevalence in the Adolescents
Pamela Siller, MD Westchester Medical Center, Valhalla, NY
Shajiuddin F. Mohammed, MD Westchester Medical Center, Valhalla, NY
Carmel Foley, MD Cohen Children's Medical Center of New York, New Hyde Park, NY
 
5.21
The Impact of a Community-Based Executive Function Intervention for Low-Income Children With ADHD and Autism Spectrum Disorder
Bruno Anthony, PhD Georgetown University Center for Child and Human Development, Washington, DC
Lauren Kenworthy, PhD Center for Autism Spectrum Disorders, Children's National Healthy Systems, Rockville, MD
Laura Anthony, PhD Center for Autism Spectrum Disorders, Children's National Healthy Systems, Rockville, MD
Jonathan Safer-Lichtenstein, BA Georgetown University Center for Child and Human Development, Silver Spring, MD
Kristin Meyering Georgetown University Center for Child and Human Development, Riverside, CT
 
5.22
Socio-Demographic Characteristics and Adaptive Functioning Profile of Children With Intellectual Disability in Pakistan
Samreen Afzal, MSC Department of Psychiatry and Behavioral Sciences, Faisalabad Pakistan
Salma Malik, MD, MS Institute of Living and Hartford Hospital, Farmington, CT
Imtiaz Dogar, MD Punjab Medical College, Faisalabad Pakistan
Michelle Durham, MD, MPH Boston University, Boston, MA
Mohsin A. Cheema, MBBS Fatima Memorial Hospital, Lahore Pakistan
Muhammad Waqar Azeem, MD Albert J. Solnit Children's Center, Rocky Hill, CT
 
5.23
Anxiety and Depression Among Parents of Children With Intellectual Disability and Their Ways of Coping in Lahore, Pakistan
Muhammad H. Sheikh, MBBS King Edward Medical University and Mayo Hospital, Lahore Pakistan
Muhammad Waqar Azeem, MD Albert J. Solnit Children's Center, Rocky Hill, CT
Sania Ashraf, MBBS King Edward Medical University and Mayo Hospital, Lahore Pakistan
Nazish Imran, MBBS, MRCPsych King Edward Medical University, Lahore Pakistan
Sadia Hussain, MSC King Edward Medical University and Mayo Hospital, Lahore Pakistan
 
5.24
Psychosocial Factors Associated With Conduct Disturbance Traits Among High School Students in Istanbul
Parna R. Prajapati, MD, MPH Cooper University Hospital, Camden, NJ
Alican Dalkilic, MD, MPH Cooper University Hospital, Camden, NJ
Hatice Burakgazi Yilmaz, MD Cooper University Hospital, Cherry Hill, NJ
Andres J. Pumariega, MD Cooper University Hospital and Health System Cooper Medical School of Rowan University, Camden, NJ
 
5.25
Association of Sleep Duration With Sociodemographic Factors, Physical and Mental Health-Related Factors, and Risk-Taking Behaviors in Korean Adolescents : A Nationwide Cross-Sectional Survey
Aran MIN, MD Hanyang University Medical Center, Seoul South Korea
Dong H. Ahn, MD, PhD Hanyang University Hospital, Seoul South Korea
Seongjin Cho Hanyang University Hospital, Seoul South Korea
 
5.26
Analysis of Blood-Based Gene Expression Signature in Autism Spectrum Disorder
Ilbin KIM, MD Hanyang University Medical Center, Seoul South Korea
Aran MIN, MD Hanyang University Medical Center, Seoul South Korea
Dong H. Ahn, MD, PhD Hanyang University Medical Center, Seoul South Korea
Sungjin Jo, MD Hanyang University Medical Center, Seoul South Korea
Donghoon OH, PhD Hanyang University Medical Center, Seoul South Korea
 
5.27
Feeding and Eating Disorders: Diagnostic Changes With Transition From DSM-IV-TR to DSM-5 at the Center for Pediatric Eating Disorders
Kelsey M. D'Amore, BA Children's Medical Center at Legacy, Plano, TX
Melissa Michelsen, MS Children's Medical Center at Legacy, Plano, TX
Briana Sacco, MD Children's Medical Center at Legacy, Plano, TX
 
5.28
Reconsidering “Refeeding Labs”: A Retrospective Review of the Utility and Charges of Screening Lab Studies for Refeeding Syndrome in Adolescent Inpatients With Eating Disorders
Jonathan W. Kole, MD Alpert Medical School of Brown University, Hasbro Children's Hospital, Bradley Hospital, Providence, RI
Kelly Fitzgerald, BA Alpert Medical School of Brown University, Providence, RI
Kathryn K. Ridout, MD, PhD Alpert Medical School of Brown University, Providence, RI
Samuel J. Ridout, MD, PhD Alpert Brown University School of Medicine, Providence, RI
Abigail Donaldson Alpert Medical School of Brown University, Hasbro Children's Hospital, Providence, RI
Brian Alverson, MD Alpert Medical School of Brown University, Hasbro Children's Hospital, Providence, RI
 
5.29
Bothersome Tics in Patients With Chronic Tic Disorders: Characteristics and Individualized Response to Behavior Therapy
Joseph F. McGuire, PhD University of California, Los Angeles, Los Angeles, CA
John Piacentini, PhD UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA
Lawrence Scahill, PhD Emory University School of Medicine, Atlanta, GA
Douglas W. Woods, PhD Texas A&M University, College Station, TX
Robert Villarreal, MS University of Texas Health Science Center at San Antonio, San Antonio, TX
Sabine Wilhelm, PhD Harvard Medical School and Massachusetts General Hospital, Boston, MA
John T. Walkup, MD Weill Cornell Medical College, New York, NY
Alan L. Peterson, PhD University of Texas Health Science Center at San Antonio, San Antonio, TX
 
5.30
The Relationship Among Tic Symptoms, Expressed Emotion, and Quality of Life in Tic Disorder Patients
Soyoung Park, MD Korea University College of Medicine, Guro-gu South Korea
Eunsoo Suh, MD Korea University College of Medicine, Seoul South Korea
Lee Moon-Soo, MD Korea University College of Medicine, Seoul South Korea
 
5.31
Weapon Carrying and Psychopathic-Like Features in a Population-Based Sample of Finnish Adolescents
Suvi J. Saukkonen, MD University of Helsinki, Helsinki Finland
Taina Laajasalo, PhD Helsinki University Central Hospital, Helsinki Finland
Markus Jokela, PhD University of Helsinki, Helsinki Finland
Janne Kivivuori, ScD National Research Institute of Legal Policy, Helsinki Finland
Venla Salmi, PhD National Research Institute of Legal Policy, Helsinki Finland
Eeva T. Aronen, PhD Helsinki University Central Hospital, Helsinki Finland
 
5.32
A New Formulation of Methylphenidate: Phase 3 Study of the Efficacy and Tolerability of an Extended-Release Orally Disintegrating Tablet in Children 6-12 Years of Age With ADHD
Ann Catherine Childress, MD Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas, NV
Scott H. Kollins, PhD Duke University Medical Center, Durham, NC
Andrew Cutler, MD Florida Clinical Research Center, LLC, Bradenton, FL
Andrea Marraffino, PhD Lakeside Behavioral Healthcare, Orlando, FL
Carolyn R. Sikes, PhD NEOS Therapeutics Inc., Grand Prairie, TX
 
5.33
The Pharmacokinetic Properties of a Novel Extended-Release Oral Disintegrating Tablet Formulation of Methylphenidate in Children and Adolescents With ADHD
Ann Catherine Childress, MD Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas, NV
Jeffrey G. Stark, PhD Worldwide Clinical Trials, Austin, TX
Russ McMahen NEOS Therapeutics Inc., Grand Prairie, TX
Mark Tengler NEOS Therapeutics Inc., Grand Prairie, TX
Carolyn R. Sikes, PhD NEOS Therapeutics Inc., Grand Prairie, TX
 
5.34
GREAT: Groups Receiving Exercise as Treatment
Richard R. Dopp, MD University of Michigan, Ann Arbor, MI
Ann Mooney, MSW University of Michigan, Ann Arbor, MI
Emily Munier, BS University of Michigan, Ann Arbor, MI
Zachary Miklja University of Michigan, Ann Arbor, MI
Dillon Coplai University of Michigan, Ann Arbor, MI
 
5.35
Characterizing Anhedonia Severity in Depressed Children and Adolescents
Zohra Chahal, BS The University of Texas Southwestern Medical Center, Dallas, TX
Kristin L. Wolfe, MRC University of Texas Southwestern Medical Center, Dallas, TX
Taryn Mayes, MS University of Texas Southwestern Medical Center, Flower Mound, TX
Paul Nakonezny, PhD University of Texas Southwestern Medical Center at Dallas, Dallas, TX
Betsy D. Kennard, PsyD Children's Health, Children's Medical Center, Dallas, TX
Graham J. Emslie, MD University of Texas Southwestern Medical Center at Dallas, Dallas, TX
 
5.36
An Observational Study of Bullying As a Contributing Factor in Youth Suicide in Toronto
Amy Cheung, MD University of Toronto, Toronto, ON
Mark Sinyor, MD University of Toronto, Toronto, ON
Ayal Schaffer, MD University of Toronto, Toronto, ON
 
5.37
Comparison of Lifetime Symptoms Between Gender in Children and Adolescents With Bipolar Disorder
Lee Fu-I, MD University of São Paulo Medical School, São Paulo Brazil
Miguel A. Angelo Boarati, MD School of Medicine, University of São Paulo, São Paulo Brazil
Ana Paula Ferreira-Maia, MD University of São Paulo Medical School, São Paulo Brazil
Yuan-Pang Wang, PhD University of São Paulo, São Paulo Brazil
 
5.38
Is TPO-Abs Positivity an Endophenotype for Bipolar Disorder? Results From Two Follow-Up Studies in Bipolar Families and Bipolar Twins
Gijsje Snijders, MD University Medical Center Utrecht, Utrecht Netherlands
Lot de Witte, MD University Medical Center Utrecht, Utrecht Netherlands
H.A. Drexhage, MD, PhD ErasmusMC, Rotterdam Netherlands
Manon Hillegers, MD, PhD university Medical Center Utrecht, Utrecht Netherlands
 
5.39
DSM-5 Mixed Specifier for Manic Episodes: Asenapine Efficacy in Pediatric Patients With a Manic or Mixed Episode Associated with Bipolar I Disorder
Roger S. McIntyre, MD, FRCPC University Health Network, University of Toronto, Toronto, ON
Ronald Landbloom, MD Merck & Co., Inc., Whitehouse Station, NJ
Carla Hundt, MD Forest Research Institute, an affiliate of Actavis, Inc., Jersey City, NJ
Xiao Wu, PhD Forest Research Institute, an affiliate of Actavis, Inc., Jersey City, NJ
Robert L. Findling, MD, MBA The Johns Hopkins University and Kennedy Krieger Institute, Baltimore, MD
 
5.40
Long-Term Safety of Asenapine in Pediatric Patients Diagnosed With Bipolar I Disorder
Robert L. Findling, MD, MBA The Johns Hopkins University and Kennedy Krieger Institute, Baltimore, MD
Ronald Landbloom, MD Merck & Co., Inc., Whitehouse Station, NJ
Mary Mackle, PhD Merck & Co., Inc., Whitehouse Station, NJ
Xiao Wu, PhD Forest Research Institute, an affiliate of Actavis, Inc., Jersey City, NJ
Linda Snow-Adami, BA Merck & Co., Inc., Whitehouse Station, NJ
Carla Hundt, MD Forest Research Institute, an affiliate of Actavis, Inc., Jersey City, NJ
 
5.41
Metabolic Profile of Asenapine in Pediatric Patients Diagnosed With Bipolar I Disorder With and Without ADHD and Stimulant Use
Rakesh Jain, MD Texas Tech University, School of Medicine, Midland, TX
Ronald Landbloom, MD Merck & Co., Inc., Whitehouse Station, NJ
Mary Mackle, PhD Merck & Co., Inc., Whitehouse Station, NJ
Xiao Wu, PhD Forest Research Institute, an affiliate of Actavis, Inc., Jersey City, NJ
Linda Snow-Adami, BA Merck & Co., Inc., Whitehouse Station, NJ
Carla Hundt, MD Forest Research Institute, an affiliate of Actavis, Inc., Jersey City, NJ
Robert L. Findling, MD, MBA The Johns Hopkins University, Baltimore, MD
 
5.42
Impact of a Sequential Treatment Strategy on Residual Symptoms in Youth With Major Depressive Disorder
Betsy D. Kennard, PsyD Children's Health, Children's Medical Center, Dallas, TX
Michael Emslie University of Texas Southwestern Medical Center, Dallas, TX
Katherine Kennard, BA University of Texas Southwestern Medical Center, Dallas, TX
Taryn Mayes, MS University of Texas Southwestern Medical Center, Flower Mound, TX
Kristin L. Wolfe, MRC University of Texas Southwestern Medical Center, Dallas, TX
Paul Nakonezny, PhD University of Texas Southwestern Medical Center at Dallas, Dallas, TX
Graham J. Emslie, MD University of Texas Southwestern Medical Center at Dallas, Dallas, TX
 
5.43
Psychosocial Characteristics of Completed Suicide Among Children and Adolescents in South Korea: Analyzing Teachers' Reports for Suicidal Death of the Students
Mi-jeong Lee, PhD Institute of Suicide and School Mental Health, Hallym University, Gyeonggi-do South Korea
Yongsil Kweon, MD Catholic University of Korea and Uijongbu St. Mary's Hospital, Uijeongbu South Korea
Hyun Ju Hong, MD Hallym University, Anyang Kyunggi-do South Korea
 
5.44
Meta-Analyses of Attentional Function in Bipolar Disorder Patients: Pediatric and Adult Age Groups
Moon-Soo Lee, MD Korea University College of Medicine, Seoul South Korea
Purnima Anumagalla, MD University of Illinois at Chicago College of Medicine, Chicago, IL
Prasanth Talluri, MD University of Illinois at Chicago College of Medicine, Chicago, IL
Mani N. Pavuluri, MD Pediatric Brain Research & Intervention Center and University of Illinois at Chicago, Chicago, IL
 
5.45
Psychosocial Treatment Utilization Among Adolescents With Bipolar Disorder
Danielle Omrin, MSW Sunny Brook Health Sciences, Toronto, ON
Adam Iskric, MSC Centre for Youth Bipolar Disorder, Toronto, ON
Jordan Collins, PhD Sunny Brook Health Sciences, Toronto, ON
Vanessa Timmins, BS Sunny Brook Health Sciences, Toronto, ON
Antonette Scavone, BS Sunny Brook Health Sciences, Toronto, ON
Benjamin I. Goldstein, MD, PhD Sunny Brook Health Sciences, Toronto, ON
 
5.46
Suicide Ideation and Early Alcohol Use in One Latino Subgroup: The Role of Gender and Context
Ana Ortin, MS New York Psychiatric Institute and Columbia University Medical College, New York, NY
Maria A. Ramos-Olazagasti, PhD Columbia University and New York State Psychiatric Institute, New York, NY
Glorisa Canino, PhD University of Puerto Rico, Rio Piedras, PR
Hector R. Bird, MD Columbia University, San Juan, PR
Cristiane S. Duarte, PhD Columbia University, New York, NY
 
5.47
Comparison of the Lifetime Psychiatric Disorders Between Offspring of Parents With Bipolar Disorder and Community Controls Offspring's
Juan David Palacio, MD Universidad de Antioquia, Medellín Colombia
Cristian PeÒa, MD Universidad de Antioquia, Medellín Colombia
Esteban Uribe, MD Universidad de Antioquia, Medellín Colombia
Paula Duque, MD Universidad de Antioquia, Medellín Colombia
Carlos LÛpez-Jaramillo, DrPH Universidad de Antioquia, Medellín Colombia
 
5.48
Resting-State Functional Connectivity Among Adolescents in Remission From Major Depression
Amy T. Peters, MA University of Illinois at Chicago, Chicago, IL
Rachel H. Jacobs, PhD Institute for Juvenile Research, Chicago, IL
Claudia Feldhaus, BA University of Illinois at Chicago, Chicago, IL
Catherine Dion, BA University of Illinois at Chicago, Chicago, IL
Scott A. Langenecker, PhD University of Illinois at Chicago, Chicago, IL
 
5.49
Treatment Expectancy and Its Impact on Treatment Outcomes in Depressed Youth
Katherine V. Rial, BS University of Texas Southwestern Medical Center, Dallas, TX
Kristin L. Wolfe, MRC University of Texas Southwestern Medical Center, Dallas, TX
Sarita Patel, BA Children's Health, Dallas, TX
Aleksandra A. Foxwell, PhD Children's Health, Dallas, TX
Taryn Mayes, MS University of Texas Southwestern Medical Center, Dallas, TX
Jessica King, BA Children's Health, Dallas, TX
Paul Nakonezny, PhD University of Texas Southwestern Medical Center at Dallas, Dallas, TX
Betsy D. Kennard, PsyD Children's Health, Children's Medical Center, Dallas, TX
Graham J. Emslie, MD University of Texas Southwestern Medical Center at Dallas, Dallas, TX
 
5.50
Alterations of Brain Structures in Pediatric Bipolar Disorder Patients With and Without Psychotic Symptoms
Weijia Gao, MD Zhejiang University, School of Medicine, Childrens Hospital, Hangzhou China
Dali Lu, MD Xian Yue Hospital of Xiamen City, Xiamen China
Qian Xiao, MD Second Xiangya Hospital of Central South University, Changsha China
Lin-Yan Su, MD Second Xiangya Hospital of Central South University, Mental Health Institute, Changsha China
 
5.51
Hopelessness as a Predictor of Suicidal Ideation in Depressed Male and Female Youth After Acute Treatment With Fluoxetine
Kristin L. Wolfe, MRC University of Texas Southwestern Medical Center, Dallas, TX
Paul Nakonezny, PhD University of Texas Southwestern Medical Center at Dallas, Dallas, TX
Zohra Chahal, BS The University of Texas Southwestern Medical Center, Dallas, TX
Katherine Rose, PsyD Children's Medical Center, Dallas, TX
Taryn Mayes, MS University of Texas Southwestern Medical Center, Flower Mound, TX
Betsy D. Kennard, PsyD Children's Health, Children's Medical Center, Dallas, TX
Graham J. Emslie, MD University of Texas Southwestern Medical Center at Dallas, Dallas, TX
 
5.52
Non-Suicidal Self-Injury in Adolescents With Bipolar Disorder: Prevalence, Demographics, and Clinical Risk Factors
Adam Iskric, MSC Centre for Youth Bipolar Disorder, Toronto, ON
Vanessa Timmins, BS Sunny Brook Health Sciences, Toronto, ON
Antonette Scavone, BS Sunny Brook Health Sciences, Toronto, ON
Jordan Collins, PhD Sunny Brook Health Sciences, Toronto, ON
Benjamin I. Goldstein, MD, PhD Sunny Brook Health Sciences, Toronto, ON
 
5.53
Self-Esteem in Individuals at Clinical High Risk for Psychosis, Individuals With Schizophrenia, and Healthy Control
Caridad Benavides, MD Columbia University, New York, NY
Ragy Girgis, MD Columbia University, New York, NY
David Kimhy, PhD Columbia University, New York, NY

See more of: New Research Poster
Copyright © 2015 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.